請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45551完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳俊任(Chun-Jen Chen) | |
| dc.contributor.author | Wei-Ting Li | en |
| dc.contributor.author | 李威霆 | zh_TW |
| dc.date.accessioned | 2021-06-15T04:26:41Z | - |
| dc.date.available | 2012-08-21 | |
| dc.date.copyright | 2009-08-21 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-08-20 | |
| dc.identifier.citation | 1.Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256.
2.Shahab, I., and K. D. Nolph. 2006. MIA syndrome in peritoneal dialysis: prevention and treatment. Contrib Nephrol 150:135-143. 3.Hurlimann, D., F. Enseleit, and F. Ruschitzka. 2004. [Rheumatoid arthritis, inflammation, and atherosclerosis]. Herz 29:760-768. 4.Ferrero-Miliani, L., O. H. Nielsen, P. S. Andersen, and S. E. Girardin. 2007. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147:227-235. 5.Ramzi S. Cotran, V. K., Tucker Collins. 1998. Robbins pathologic basis of disease. 6th ed. W.B Saunders Company., Philadelphia. 6.Wilkins, L. W. 2005. Pathophysiology: Concepts of Altered Health States. 7th ed. J.B. Lippincott Company., Philadelphia. 7.Babu, K. S., D. E. Davies, and S. T. Holgate. 2004. Role of tumor necrosis factor alpha in asthma. Immunol Allergy Clin North Am 24:583-597, v-vi. 8.Clyne, A. M., H. Zhu, and E. R. Edelman. 2008. Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose. J Cell Physiol 217:86-92. 9.Bessis, A., D. Bernard, and A. Triller. 2005. Tumor necrosis factor-alpha and neuronal development. Neuroscientist 11:277-281. 10.Cavin, L. G., M. Venkatraman, V. M. Factor, S. Kaur, I. Schroeder, F. Mercurio, A. A. Beg, S. S. Thorgeirsson, and M. Arsura. 2004. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis. Cancer Res 64:7030-7038. 11.Ksontini, R., S. L. MacKay, and L. L. Moldawer. 1998. Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation. Arch Surg 133:558-567. 12.Motivala, S. J., D. Khanna, J. FitzGerald, and M. R. Irwin. 2008. Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor alpha antagonists. Arthritis Rheum 58:376-383. 13.Weller, A., S. Isenmann, and D. Vestweber. 1992. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem 267:15176-15183. 14.Yamaki, K., L. Lindbom, H. Thorlacius, P. Hedqvist, and J. Raud. 1998. An approach for studies of mediator-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 123:381-389. 15.Dinarello, C. A. 2000. Proinflammatory cytokines. Chest 118:503-508. 16.Werman, A., R. Werman-Venkert, R. White, J. K. Lee, B. Werman, Y. Krelin, E. Voronov, C. A. Dinarello, and R. N. Apte. 2004. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A 101:2434-2439. 17.Lonnemann, G., G. Engler-Blum, G. A. Muller, K. M. Koch, and C. A. Dinarello. 1995. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int 47:845-854. 18.Hurgin, V., D. Novick, A. Werman, C. A. Dinarello, and M. Rubinstein. 2007. Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc Natl Acad Sci U S A 104:5044-5049. 19.Hacham, M., S. Argov, R. M. White, S. Segal, and R. N. Apte. 2002. Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice. Eur Cytokine Netw 13:55-65. 20.Kurt-Jones, E. A., D. I. Beller, S. B. Mizel, and E. R. Unanue. 1985. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A 82:1204-1208. 21.Kaplanski, G., C. Farnarier, S. Kaplanski, R. Porat, L. Shapiro, P. Bongrand, and C. A. Dinarello. 1994. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84:4242-4248. 22.Kamari, Y., R. Werman-Venkert, A. Shaish, A. Werman, A. Harari, A. Gonen, E. Voronov, I. Grosskopf, Y. Sharabi, E. Grossman, Y. Iwakura, C. A. Dinarello, R. N. Apte, and D. Harats. 2007. Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 195:31-38. 23.Schiffmann, E., H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith, and E. L. Becker. 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 114:1831-1837. 24.Schiffmann, E., B. A. Corcoran, and S. M. Wahl. 1975. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 72:1059-1062. 25.Fernandez, H. N., P. M. Henson, A. Otani, and T. E. Hugli. 1978. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 120:109-115. 26.Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264-265. 27.Kunkel, S. L., N. W. Lukacs, and R. M. Strieter. 1994. The role of interleukin-8 in the infectious process. Ann N Y Acad Sci 730:134-143. 28.Seely, A. J., J. L. Pascual, and N. V. Christou. 2003. Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit Care 7:291-307. 29.Zlotnik, A., J. Morales, and J. A. Hedrick. 1999. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1-47. 30.Bacon, K. B., and J. J. Oppenheim. 1998. Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev 9:167-173. 31.Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314. 32.Granger, D. N., and P. Kubes. 1994. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675. 33.Zimmerman, G. A., S. M. Prescott, and T. M. McIntyre. 1992. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93-100. 34.Smith, W. B., J. R. Gamble, and M. A. Vadas. 1994. The role of granulocyte-macrophage and granulocyte colony-stimulating factors in neutrophil transendothelial migration: comparison with interleukin-8. Exp Hematol 22:329-334. 35.Vercellotti, G. M., H. Q. Yin, K. S. Gustafson, R. D. Nelson, and H. S. Jacob. 1988. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71:1100-1107. 36.Wozniak, A., W. H. Betts, G. McLennan, and R. Scicchitano. 1993. Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity. Immunology 78:629-634. 37.Partrick, D. A., F. A. Moore, E. E. Moore, C. C. Barnett, Jr., and C. C. Silliman. 1996. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 4:194-210. 38.Moore, E. E., F. A. Moore, R. J. Franciose, F. J. Kim, W. L. Biffl, and A. Banerjee. 1994. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 37:881-887. 39.Tanaka, H., H. Ogura, J. Yokota, H. Sugimoto, T. Yoshioka, and T. Sugimoto. 1991. Acceleration of superoxide production from leukocytes in trauma patients. Ann Surg 214:187-192. 40.Boxer, L., and D. C. Dale. 2002. Neutropenia: causes and consequences. Semin Hematol 39:75-81. 41.Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int Immunol 17:1-14. 42.Robinson, M. J., D. Sancho, E. C. Slack, S. LeibundGut-Landmann, and C. Reis e Sousa. 2006. Myeloid C-type lectins in innate immunity. Nat Immunol 7:1258-1265. 43.Inohara, Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74:355-383. 44.Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737. 45.Majno, G., M. La Gattuta, and T. E. Thompson. 1960. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virchows Arch Pathol Anat Physiol Klin Med 333:421-465. 46.Bianchi, M. E. 2007. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1-5. 47.Huynh, M. L., V. A. Fadok, and P. M. Henson. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109:41-50. 48.Chung, E. Y., S. J. Kim, and X. J. Ma. 2006. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 16:154-161. 49.Majno, G., and I. Joris. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15. 50.Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377. 51.Tsung, A., R. Sahai, H. Tanaka, A. Nakao, M. P. Fink, M. T. Lotze, H. Yang, J. Li, K. J. Tracey, D. A. Geller, and T. R. Billiar. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143. 52.Ohashi, K., V. Burkart, S. Flohe, and H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558-561. 53.Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167:2887-2894. 54.Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99-111. 55.Johnson, G. B., G. J. Brunn, Y. Kodaira, and J. L. Platt. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233-5239. 56.Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276:31332-31339. 57.Scheibner, K. A., M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton. 2006. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177:1272-1281. 58.Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607. 59.Chen, C. J., H. Kono, D. Golenbock, G. Reed, S. Akira, and K. L. Rock. 2007. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851-856. 60.Romson, J. L., B. G. Hook, S. L. Kunkel, G. D. Abrams, M. A. Schork, and B. R. Lucchesi. 1983. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016-1023. 61.Hall, T. S., M. A. Breda, W. A. Baumgartner, A. M. Borkon, J. Brawn, G. M. Hutchins, and B. A. Reitz. 1987. The role of leukocyte depletion in reducing injury to the lung after hypothermic ischemia. Curr Surg 44:137-139. 62.Sadasivan, K. K., D. L. Carden, M. B. Moore, and R. J. Korthuis. 1997. Neutrophil mediated microvascular injury in acute, experimental compartment syndrome. Clin Orthop Relat Res:206-215. 63.Liu, Z. X., D. Han, B. Gunawan, and N. Kaplowitz. 2006. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43:1220-1230. 64.Ghio, A. J., T. P. Kennedy, G. E. Hatch, and J. S. Tepper. 1991. Reduction of neutrophil influx diminishes lung injury and mortality following phosgene inhalation. J Appl Physiol 71:657-665. 65.Dovi, J. V., L. K. He, and L. A. DiPietro. 2003. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73:448-455. 66.Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat Rev Immunol 8:279-289. 67.Oliveira, S. H., C. Canetti, R. A. Ribeiro, and F. Q. Cunha. 2008. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 31:36-46. 68.Elkon, K. B. 2007. IL-1alpha responds to necrotic cell death. Nat Med 13:778-780. 69.Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-1325. 70.Eigenbrod, T., J. H. Park, J. Harder, Y. Iwakura, and G. Nunez. 2008. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol 181:8194-8198. 71.Thorlacius, H., J. Raud, S. Rosengren-Beezley, M. J. Forrest, P. Hedqvist, and L. Lindbom. 1994. Mast cell activation induces P-selectin-dependent leukocyte rolling and adhesion in postcapillary venules in vivo. Biochem Biophys Res Commun 203:1043-1049. 72.Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192:1441-1452. 73.Schramm, R., T. Schaefer, M. D. Menger, and H. Thorlacius. 2002. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 72:1122-1132. 74.Armstrong, D. A., J. A. Major, A. Chudyk, and T. A. Hamilton. 2004. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 75:641-648. 75.Wang, Y., and H. Thorlacius. 2005. Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol 145:1062-1068. 76.Lippert, U., M. Artuc, A. Grutzkau, A. Moller, A. Kenderessy-Szabo, D. Schadendorf, J. Norgauer, K. Hartmann, R. Schweitzer-Stenner, T. Zuberbier, B. M. Henz, and S. Kruger-Krasagakes. 1998. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 161:2600-2608. 77.Nilsson, G., J. A. Mikovits, D. D. Metcalfe, and D. D. Taub. 1999. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood 93:2791-2797. 78.Ishida, Y., T. Kondo, K. Tsuneyama, P. Lu, T. Takayasu, and N. Mukaida. 2004. The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J Leukoc Biol 75:59-67. 79.Gardner, C. R., J. D. Laskin, D. M. Dambach, H. Chiu, S. K. Durham, P. Zhou, M. Bruno, D. R. Gerecke, M. K. Gordon, and D. L. Laskin. 2003. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol 192:119-130. 80.Boess, F., M. Bopst, R. Althaus, S. Polsky, S. D. Cohen, H. P. Eugster, and U. A. Boelsterli. 1998. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. Hepatology 27:1021-1029. 81.Stanford, S. J., J. R. Pepper, and J. A. Mitchell. 2000. Cyclooxygenase-2 regulates granulocyte-macrophage colony-stimulating factor, but not interleukin-8, production by human vascular cells: role of cAMP. Arterioscler Thromb Vasc Biol 20:677-682. 82.Westlin, W. F., and M. A. Gimbrone, Jr. 1993. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 142:117-128. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45551 | - |
| dc.description.abstract | 細胞受損是引起發炎反應的原因之一，同時也是一些疾病的致病原因，其中的機制到目前為止還尚未十分明瞭，我們在這裡針對此發炎反應，探討1) IL-1α 產生的機制、2) 肥大細胞 (mast cell) 在發炎反應中的角色、3) tumor necrosis factor (TNF)-α 的功能 及 4) 嗜中性白血球 (neutrophil) 活化的機制。研究中發現 IL-1α 很可能是由壞死細胞 (necrotic cell) 中釋放出來的 damage-associated molecular pattern (DAMP)。另外，在藉由藥物 compound 48/80 使腹腔中肥大細胞缺失後，以壞死細胞誘導產生腹膜炎 (peritonitis)的模式中，發現肥大細胞缺失顯著降低腹腔中嗜中性白血球的滲入(neutrophil infiltration)，但對於單核白血球 (monocytes) 的滲入卻沒有顯著影響。另一方面，TNFR1 (TNF receptor 1) 缺陷小鼠以 acetaminophen (AAP) 誘導的肝臟損傷模式 (liver injury model) 中，結果顯示 TNFR1 缺陷小鼠相較於野生型 (wild-type)，組織損傷程度有明顯減輕，而肝組織中嗜中性白血球滲入的情形也有下降的趨勢。最後，以壞死細胞直接或間接刺激嗜中性白血球，結果顯示壞死細胞能夠直接或間接活化嗜中性白血球釋放 O2− ，這也許與壞死細胞所釋放的 IL-1α 有關。這些結果顯示了 IL-1α、肥大細胞、TNF 及嗜中性白血球的活化在細胞受損引起發炎反應的機制中，各自扮演相當重要的角色，但其中的關聯性尚需更進一步實驗證實。 | zh_TW |
| dc.description.abstract | Cell injury is one of the principal stimuli of inflammation, which leads to the pathogenesis of many diseases. Here our research aimed to further delineate the mechanisms behind this type of sterile inflammation. Our experiments were designed to address four aspects including 1) the source of interleukin-1α (IL-1α) generation, 2) the role of mast cells in inflammation, 3) the function of tumor necrosis factor (TNF)-α in sterile inflammation, and 4) the mechanisms of neutrophil activation. We found that IL-1α is potentially a damage-associated molecular pattern (DAMP) released from necrotic cells. In a cell injury-induced peritonitis model, we showed that neutrophil infiltration was markedly reduced in mice depleted of mast cells with compound 48/80. In the acetaminophen (AAP)-induced liver injury model, our data revealed that the level of injury was markedly reduced in TNFR1-deficient mice, and leukocyte infiltration was also affected. We also analyzed whether neutrophils could be stimulated by necrotic cells directly and/or indirectly, and our results showed that necrotic cells could both directly and indirectly activate neutrophils to release O2−, which might be associated with the IL-1α released from necrotic cells. Overall our findings provide new insights on how interleukin-1α (IL-1α), mast cells, and TNF-α, may play their roles in regulating the sterile inflammation induced by cell injury, and how neutrophils are activated once they are recruited to the injured site. Further studies will be carried out to support our models of how these factors link each other in the sterile inflammatory response. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T04:26:41Z (GMT). No. of bitstreams: 1 ntu-98-R96b47109-1.pdf: 7579343 bytes, checksum: c9a8aab8b69bf35cac20678832da674d (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | Abstract i
中文摘要 iii Abbreviation iv Introduction 1 1. Acute and chronic inflammation 1 2. The process of acute inflammation 2 3. Proinflammatory cytokines 2 4. Proinflammatory chemokines 4 5. Regulation of leukocyte recruitment and functions in inflammation 5 6. Microbial infection-induced inflammation and pathogen recognition 7 7. Cell death-induced sterile inflammation and danger signals 8 8. Sterile inflammation and disease 10 9. Rationale of the study 10 Specific aims 12 Materials and Methods 13 1. Animals and cells 13 2. Cell injury induction by freeze-thaw method and IL-1α assay 13 3. Immunoabsorption of IL-1α in necrotic cell lysate. 13 4. Depletion of peritoneal mast cell 14 5. Necrotic cell-induced peritonitis 14 6. Analysis of peritoneal cells by flow cytometry 15 7. Acetaminophen (AAP)-induced liver injury and myeloperoxidase (MPO) activity assay 16 8. Histological and immunohistochemical analysis 16 9. Isolation of neutrophils from peritoneal fluid 17 10. Superoxide formation assay 18 11. Statistical analysis 19 Results 20 1. IL-1α is potentially a danger signal released from necrotic cells. 20 2. Role of mast cells in cell injury-induced sterile inflammation. 24 3. Role of TNF-α in acetaminophen (AAP)-induced liver injury and inflammation. 29 4. Mechanisms of neutrophil activation induced by necrotic cells 35 Discussion 37 References 42 Appendix 56 Materials 56 | |
| dc.language.iso | en | |
| dc.subject | 嗜中性白血球 | zh_TW |
| dc.subject | 細胞損傷 | zh_TW |
| dc.subject | 發炎反應 | zh_TW |
| dc.subject | 肥大細胞 | zh_TW |
| dc.subject | neutrophil | en |
| dc.subject | cell injury | en |
| dc.subject | inflammation | en |
| dc.subject | interleukin-1α | en |
| dc.subject | tumor necrosis factor (TNF)-α | en |
| dc.subject | mast cell | en |
| dc.title | 細胞受損引起發炎反應機轉之研究 | zh_TW |
| dc.title | Mechanism of sterile inflammation triggered by cell injury | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 許秉寧(Ping-Ning Hsu),陳念榮(Nien-Jung Chen) | |
| dc.subject.keyword | 細胞損傷,發炎反應,肥大細胞,嗜中性白血球, | zh_TW |
| dc.subject.keyword | cell injury,inflammation,interleukin-1α,tumor necrosis factor (TNF)-α,mast cell,neutrophil, | en |
| dc.relation.page | 57 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-08-20 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 微生物與生化學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 7.4 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。